David Weber
Interventional Pain Medicine · Louisville, KYNPI 1811921216
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 101 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by AbbVie at 26.5% of the total. Reporting peaked in 2019 at $704 and has fallen 94.2% since, to $41 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in KY, where the typical reported total is $3,169.
Across 101 payments — averaging $14.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$394
- Amgen$279
- Daiichi Sankyo Inc.$277
- Scilex Pharmaceuticals Inc.$145
- Pfizer$132
- Boston Scientific$82
- plus $178 from 6 others
What the payments were for
- Food & beverage$1,486100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 28 | $394 |
| Amgen | 13 | $279 |
| Daiichi Sankyo Inc. | 24 | $277 |
| Scilex Pharmaceuticals Inc. | 12 | $145 |
| Pfizer | 8 | $132 |
| Boston Scientific | 4 | $82 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $81 |
| Avanos Medical | 2 | $31 |
| Exact Sciences | 1 | $21 |
| Ferring Pharmaceuticals Inc. | 1 | $17 |
| Novartis | 1 | $14 |
| Shionogi Inc | 1 | $14 |
How this compares
$1,486 in reported general payments places this provider in the 30th percentile of 55 interventional pain medicine providers in Kentucky.
See all interventional pain medicine providers in Kentucky →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine | 36 | $13,893 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 528 | $9,060 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 395 | $7,091 |
| MovantikNaloxegol Oxalate | 16 | $6,135 |
| Pregabalin | 289 | $4,156 |
| Naloxone Hcl | 32 | $2,017 |
| Celecoxib | 80 | $1,437 |
| Gabapentin | 206 | $1,394 |
| Duloxetine Hcl | 148 | $957 |
| Oxycodone Hcl | 62 | $733 |
| Tizanidine Hcl | 62 | $155 |
| Meloxicam | 77 | $115 |
| Ibuprofen | 23 | $79 |
| Topiramate | 13 | $26 |
| Cyclobenzaprine Hcl | 18 | $20 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Louisville
- Nathan LambornLouisville$10K
- Brandon SuttonLouisville$9K
- Gary ReasorLouisville$9K
- Kristal WilsonLouisville$9K
- Blake FechtelLouisville$6K
- Konrad KijewskiLouisville$6K
- Lady Christine Ong SioLouisville$5K
- Jeffrey BergLouisville$3K
- Aaron ComptonLouisville$3K
- Daniel LynchLouisville$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.